the answer to early diagnosis & treatment monitoring of alzheimer’s is in the eye
TRANSCRIPT
![Page 1: The Answer to Early Diagnosis & Treatment Monitoring of Alzheimer’s Is in the Eye](https://reader035.vdocument.in/reader035/viewer/2022062515/56649f4d5503460f94c6dde0/html5/thumbnails/1.jpg)
The Answer to Early Diagnosis & Treatment Monitoring of Alzheimer’s Is in the Eye
![Page 2: The Answer to Early Diagnosis & Treatment Monitoring of Alzheimer’s Is in the Eye](https://reader035.vdocument.in/reader035/viewer/2022062515/56649f4d5503460f94c6dde0/html5/thumbnails/2.jpg)
![Page 3: The Answer to Early Diagnosis & Treatment Monitoring of Alzheimer’s Is in the Eye](https://reader035.vdocument.in/reader035/viewer/2022062515/56649f4d5503460f94c6dde0/html5/thumbnails/3.jpg)
![Page 4: The Answer to Early Diagnosis & Treatment Monitoring of Alzheimer’s Is in the Eye](https://reader035.vdocument.in/reader035/viewer/2022062515/56649f4d5503460f94c6dde0/html5/thumbnails/4.jpg)
![Page 5: The Answer to Early Diagnosis & Treatment Monitoring of Alzheimer’s Is in the Eye](https://reader035.vdocument.in/reader035/viewer/2022062515/56649f4d5503460f94c6dde0/html5/thumbnails/5.jpg)
“The eye is quite literally a ‘real window’ to the rest of the body,” according to Dr. Noel Bairey Merz, director of the Women's Heart Center at Cedars Sinai Heart Institute in Los Angeles.
“Diagnosing illness through the eye is nothing new,” according to Dr. Marco Zarbin, chief of ophthalmology at the University of Medicine and Dentistry, New Jersey.
The retina is actually a piece of the brain that has grown into the eye and processes neural signals when it detects light, say the U Penn researchers.
![Page 6: The Answer to Early Diagnosis & Treatment Monitoring of Alzheimer’s Is in the Eye](https://reader035.vdocument.in/reader035/viewer/2022062515/56649f4d5503460f94c6dde0/html5/thumbnails/6.jpg)
The eye is part of the
brain.
The Approachable Retina:Unlike higher visual centers, the retina provides an excellent source of material for detailed anatomical, physiological, and pharmacological analyses of the neural mechanisms underlying elementary information processing by the vertebrate brain.
![Page 7: The Answer to Early Diagnosis & Treatment Monitoring of Alzheimer’s Is in the Eye](https://reader035.vdocument.in/reader035/viewer/2022062515/56649f4d5503460f94c6dde0/html5/thumbnails/7.jpg)
The Eye is Part of theCardiovascular System
“The eyes truly are unique real estate,” says Andrew Iwach, MD, executive director of the Glaucoma Center of San Francisco. “They’re the only place in the body where you can see:
a bare nerve, a bare artery, and a bare veinwithout doing any cutting. And the disease processes we see occurring in the eye are probably occurring in the rest of the body.”
By David Freeman, WebMD Feature.http://www.webmd.com/eye-health/features/what-your-eyes-say-about-your-health
![Page 8: The Answer to Early Diagnosis & Treatment Monitoring of Alzheimer’s Is in the Eye](https://reader035.vdocument.in/reader035/viewer/2022062515/56649f4d5503460f94c6dde0/html5/thumbnails/8.jpg)
![Page 9: The Answer to Early Diagnosis & Treatment Monitoring of Alzheimer’s Is in the Eye](https://reader035.vdocument.in/reader035/viewer/2022062515/56649f4d5503460f94c6dde0/html5/thumbnails/9.jpg)
“Perhaps of most importance, privileged sites and tissues create a local microenvironment that is
profoundly immunosuppressive.”
![Page 10: The Answer to Early Diagnosis & Treatment Monitoring of Alzheimer’s Is in the Eye](https://reader035.vdocument.in/reader035/viewer/2022062515/56649f4d5503460f94c6dde0/html5/thumbnails/10.jpg)
Bruch’s membrane abnormalities:
•Age 19: Bruch’s membrane thickened in 72%
•Age 33: Calcifications in the Bruch’s membrane in 59%
•Age 54: Soft drusen found in 10%
De Jong PT, et. Al. Ophthalmology. 1992 Feb;99(2):278. Erasmus University Rotterdam.
“Accumulating evidence suggests that the molecular, structural and functional properties of BM are dependent on age, genetic constitution,
environmental factors, retinal location, and disease state.”
Prog Retin Eye Res. 2010 Jan;29(1):1-18. The dynamic nature of Bruch's membrane
The Eye Through the Ages….
![Page 11: The Answer to Early Diagnosis & Treatment Monitoring of Alzheimer’s Is in the Eye](https://reader035.vdocument.in/reader035/viewer/2022062515/56649f4d5503460f94c6dde0/html5/thumbnails/11.jpg)
45 50 55 60 65 70 75 80 85 90 95
0
5
10
15
20
25
perfect geometric progression
actual ARMD data
% of ARMD as a Function of Age – Compared to a Perfect Geometric Progression
Disease doubles every 5 years after age 50
Age
Prevalence %
Incidence of Influenza
![Page 12: The Answer to Early Diagnosis & Treatment Monitoring of Alzheimer’s Is in the Eye](https://reader035.vdocument.in/reader035/viewer/2022062515/56649f4d5503460f94c6dde0/html5/thumbnails/12.jpg)
National Geographic, May 2013
![Page 13: The Answer to Early Diagnosis & Treatment Monitoring of Alzheimer’s Is in the Eye](https://reader035.vdocument.in/reader035/viewer/2022062515/56649f4d5503460f94c6dde0/html5/thumbnails/13.jpg)
Measuring Aging to determine “at risk” populations before
disease becomes clinically relevant (and costly)
![Page 14: The Answer to Early Diagnosis & Treatment Monitoring of Alzheimer’s Is in the Eye](https://reader035.vdocument.in/reader035/viewer/2022062515/56649f4d5503460f94c6dde0/html5/thumbnails/14.jpg)
The Age-Related Eye Disease Study (AREDS) – NIHAssociations between
Mortality and Ocular Disorders
AREDS: Arch. Ophthal Vol. 122, 716-726. May 2004.
•1992-1998 – 11 Clinical Centers – 4757 participants
•Indications: AMD and cataract
•Included “early” drusen or retinal pigment epithelial abnormalities
Median follow-up of 6.5 years11.2% of AREDS participants died
Predominant Cause: Cardiovascular event
![Page 15: The Answer to Early Diagnosis & Treatment Monitoring of Alzheimer’s Is in the Eye](https://reader035.vdocument.in/reader035/viewer/2022062515/56649f4d5503460f94c6dde0/html5/thumbnails/15.jpg)
[email protected] – All Rights Reserved – For A4M Workshop Attendees Only. Do NOT Copy or Distribute
Diagnose
Treat
Monitor
Confi
denti
alAREDS
#13Associais well studied
and not new (3)
15
AMD41%
Vision36%
Cataract Surgery55%
Nuclear Opacity40%
ZincSupplements
Age-Related Eye Diseases are Deadly
AMD - Over 11% Mortality in 6.5 years
![Page 16: The Answer to Early Diagnosis & Treatment Monitoring of Alzheimer’s Is in the Eye](https://reader035.vdocument.in/reader035/viewer/2022062515/56649f4d5503460f94c6dde0/html5/thumbnails/16.jpg)
The Answer to Early Diagnosis & Treatment Monitoring of Alzheimer’s Is in the Eye –
The Retina
![Page 17: The Answer to Early Diagnosis & Treatment Monitoring of Alzheimer’s Is in the Eye](https://reader035.vdocument.in/reader035/viewer/2022062515/56649f4d5503460f94c6dde0/html5/thumbnails/17.jpg)
AMD41%
7yrs
Age-Related Eye Diseases are Deadly
Wet AMD – Cat 4
![Page 18: The Answer to Early Diagnosis & Treatment Monitoring of Alzheimer’s Is in the Eye](https://reader035.vdocument.in/reader035/viewer/2022062515/56649f4d5503460f94c6dde0/html5/thumbnails/18.jpg)
Macular Degeneration– Fundus Photo
Atheromatous plaque
![Page 19: The Answer to Early Diagnosis & Treatment Monitoring of Alzheimer’s Is in the Eye](https://reader035.vdocument.in/reader035/viewer/2022062515/56649f4d5503460f94c6dde0/html5/thumbnails/19.jpg)
The Answer to Early Diagnosis & Treatment Monitoring of Alzheimer’s Is in the Eye
Drusen contains amyloid beta (Aβ) peptide, the same substance associated with the senile plaques of
Alzheimer’s disease.
![Page 20: The Answer to Early Diagnosis & Treatment Monitoring of Alzheimer’s Is in the Eye](https://reader035.vdocument.in/reader035/viewer/2022062515/56649f4d5503460f94c6dde0/html5/thumbnails/20.jpg)
Glaucoma by Optical Coherence Tomography (OCT)
Glaucoma is considered a
disease of increased inter-
ocular pressure, with no cure.
Glaucoma is actually an
inflammatory neuro-
degenerative disorder like
Alzheimer’s disease.
Retinal nerve thinning is
now appreciated to be part
of the glaucoma diagnosis.
![Page 21: The Answer to Early Diagnosis & Treatment Monitoring of Alzheimer’s Is in the Eye](https://reader035.vdocument.in/reader035/viewer/2022062515/56649f4d5503460f94c6dde0/html5/thumbnails/21.jpg)
Neurodegenerative Diseases by OCT“Compared with healthy age-matched controls, the RNFL
thickness of AD patients were much thinner as determined by OCT.”
“OCT is proven useful for the detection of early stages of AD as it allows for a non-invasive visualization of axons of the
central nervous system (CNS) providing cross-section imaging of the retina.”
“OCT could eventually supplement or even replace MRI for tracking multiple sclerosis (MS) severity and progression.”
![Page 22: The Answer to Early Diagnosis & Treatment Monitoring of Alzheimer’s Is in the Eye](https://reader035.vdocument.in/reader035/viewer/2022062515/56649f4d5503460f94c6dde0/html5/thumbnails/22.jpg)
![Page 23: The Answer to Early Diagnosis & Treatment Monitoring of Alzheimer’s Is in the Eye](https://reader035.vdocument.in/reader035/viewer/2022062515/56649f4d5503460f94c6dde0/html5/thumbnails/23.jpg)
![Page 24: The Answer to Early Diagnosis & Treatment Monitoring of Alzheimer’s Is in the Eye](https://reader035.vdocument.in/reader035/viewer/2022062515/56649f4d5503460f94c6dde0/html5/thumbnails/24.jpg)
Retinal nerve fiber layer structure abnormalities in early Alzheimer's disease: Evidence in optical coherence
tomography
Neuroscience Letters Volume 480, Issue 1, 9 August 2010, Pages 69–72
The changes of retinal nerve fiber layer thickness against eye quadrant assessed with optical coherence tomography in two eyes of a control subject (A) and two eyes of a patient with Alzheimer’s disease (B). The chart in the left panel is quantitative data curve while the images in the right panel are raw data.
![Page 25: The Answer to Early Diagnosis & Treatment Monitoring of Alzheimer’s Is in the Eye](https://reader035.vdocument.in/reader035/viewer/2022062515/56649f4d5503460f94c6dde0/html5/thumbnails/25.jpg)
The eye is part of the brain in health and disease
![Page 26: The Answer to Early Diagnosis & Treatment Monitoring of Alzheimer’s Is in the Eye](https://reader035.vdocument.in/reader035/viewer/2022062515/56649f4d5503460f94c6dde0/html5/thumbnails/26.jpg)
The Answer to Early Diagnosis & Treatment Monitoring of Alzheimer’s Is in the Eye –
The Lens
![Page 27: The Answer to Early Diagnosis & Treatment Monitoring of Alzheimer’s Is in the Eye](https://reader035.vdocument.in/reader035/viewer/2022062515/56649f4d5503460f94c6dde0/html5/thumbnails/27.jpg)
27
Measuring Alzheimer’s andCardiovascular Disease in the Lens
![Page 28: The Answer to Early Diagnosis & Treatment Monitoring of Alzheimer’s Is in the Eye](https://reader035.vdocument.in/reader035/viewer/2022062515/56649f4d5503460f94c6dde0/html5/thumbnails/28.jpg)
Nuclear Cataract
Corneal Stem CellsAlexander Schermer. The Journal of Cell Biology, 103, July 1986, 49-62.
Cortical Cataract
![Page 29: The Answer to Early Diagnosis & Treatment Monitoring of Alzheimer’s Is in the Eye](https://reader035.vdocument.in/reader035/viewer/2022062515/56649f4d5503460f94c6dde0/html5/thumbnails/29.jpg)
Eye – Brain ConnectionThe Lens and Alzheimer’s Disease
Harvard Medical School
![Page 30: The Answer to Early Diagnosis & Treatment Monitoring of Alzheimer’s Is in the Eye](https://reader035.vdocument.in/reader035/viewer/2022062515/56649f4d5503460f94c6dde0/html5/thumbnails/30.jpg)
Eye – Brain ConnectionAD 79-year-old woman AD 68-year-old woman
Dashed arc indicates extent of supranuclear cataract. Source, lancet
![Page 31: The Answer to Early Diagnosis & Treatment Monitoring of Alzheimer’s Is in the Eye](https://reader035.vdocument.in/reader035/viewer/2022062515/56649f4d5503460f94c6dde0/html5/thumbnails/31.jpg)
Misfolded Protein in Brain (Autopsy)
A Sick Eye = A Sick Brain
Misfolded Protein in Lens (living patient)
![Page 32: The Answer to Early Diagnosis & Treatment Monitoring of Alzheimer’s Is in the Eye](https://reader035.vdocument.in/reader035/viewer/2022062515/56649f4d5503460f94c6dde0/html5/thumbnails/32.jpg)
32
Measuring Neurodegeneration Lens Evaluation – Cortical Cataract Process
1. Coma Aberration
2. Pseudo Exfoliation
3. Cortical Fibril
4. Cortical Spokes5. Cortical Cataract
![Page 33: The Answer to Early Diagnosis & Treatment Monitoring of Alzheimer’s Is in the Eye](https://reader035.vdocument.in/reader035/viewer/2022062515/56649f4d5503460f94c6dde0/html5/thumbnails/33.jpg)
Measuring Neurodegeneration Cortical cataract specific wavefront aberration
Measures Optical Path Deviation (OPD)
maps the total refractive power errors of the lens, with
specificity.
The early lens changes represent the initial phase of the misfolded protein process. Aberrations occur years before pseudoX and cortical
cataract. These changes pre-date AD by 20+ years.
The accuracy of the instrument (1,440 data points in 0.4 sec) allow for monitoring the efficacy of treatment.
![Page 34: The Answer to Early Diagnosis & Treatment Monitoring of Alzheimer’s Is in the Eye](https://reader035.vdocument.in/reader035/viewer/2022062515/56649f4d5503460f94c6dde0/html5/thumbnails/34.jpg)
Measuring Neurodegeneration Cortical cataract specific wavefront aberration
34
![Page 35: The Answer to Early Diagnosis & Treatment Monitoring of Alzheimer’s Is in the Eye](https://reader035.vdocument.in/reader035/viewer/2022062515/56649f4d5503460f94c6dde0/html5/thumbnails/35.jpg)
Measuring Neurodegeneration Oculus Pentacam System
This instrument objectively quantifies a number of parameters involving the lens.
1024
•Accurate and reproducible measurement of cataract•Study progressive change in the lens•Classification of cataract•184,320 Profiles in 0.5 sec.•Measure rate of misfolded protein accumulation in relation to future development of AD
![Page 36: The Answer to Early Diagnosis & Treatment Monitoring of Alzheimer’s Is in the Eye](https://reader035.vdocument.in/reader035/viewer/2022062515/56649f4d5503460f94c6dde0/html5/thumbnails/36.jpg)
The Answer to Early Diagnosis & Treatment Monitoring of Alzheimer’s Is in the Eye –
The Next Big Thing –
Tau Protein
![Page 37: The Answer to Early Diagnosis & Treatment Monitoring of Alzheimer’s Is in the Eye](https://reader035.vdocument.in/reader035/viewer/2022062515/56649f4d5503460f94c6dde0/html5/thumbnails/37.jpg)
Measuring Tauopathies – Optic Nerve AnalyzerDr. Alzheimer’s believed this was the cause of AD (1907).
GDx Optic Nerve Analyzer – Measures Tau Protein Structure. They are uniform and polarize light.
In AD patients, uniformity is disrupted and retarded (due to changes in Tau) and light polarization changes.
Amyloid is dead as a therapeutic target.Tauopathies is emerging as the “new” strategy.
Richter-Landsberg C et. Al. Int J De Neuroscience. 2004 No;22(7):443-51
http://legacy.revoptom.com/handbook/oct02_sec4_9.htm
![Page 38: The Answer to Early Diagnosis & Treatment Monitoring of Alzheimer’s Is in the Eye](https://reader035.vdocument.in/reader035/viewer/2022062515/56649f4d5503460f94c6dde0/html5/thumbnails/38.jpg)
Summary
1024
• Sick Eye in a Sick Body• Eye Pathologies correlate to cardiovascular and
neurodegenerative disease• Eye is easily assessable• Eye may be more susceptible to disease – thus earlier onset• AMD – Vascular disease• Glaucoma – Neurodegenerative disease• RNFL – Biomarker for neurodegeneration• Lens – Cortical cataract = Alzheimer’s peptide• Lens – Nuclear cataract = Misfolded protein (stem cell
disease?) = Vascular disease• RNFL – microtubules – study tau hyperphosphorylation
![Page 39: The Answer to Early Diagnosis & Treatment Monitoring of Alzheimer’s Is in the Eye](https://reader035.vdocument.in/reader035/viewer/2022062515/56649f4d5503460f94c6dde0/html5/thumbnails/39.jpg)
The Answer to Early Diagnosis & Treatment Monitoring of Alzheimer’s Is in the Eye –
Outcome-Based Approach
![Page 40: The Answer to Early Diagnosis & Treatment Monitoring of Alzheimer’s Is in the Eye](https://reader035.vdocument.in/reader035/viewer/2022062515/56649f4d5503460f94c6dde0/html5/thumbnails/40.jpg)
Hope for the Afflicted:
1024
• Treatment versus Treatability
• “Inflammatory blockade restores adult hippocampal neurogenesis.” – Stanford U.
Interpretation: Stopping (the cause of) inflammation leads to the birth of new neurons and the restoration of brain function and memory.
![Page 41: The Answer to Early Diagnosis & Treatment Monitoring of Alzheimer’s Is in the Eye](https://reader035.vdocument.in/reader035/viewer/2022062515/56649f4d5503460f94c6dde0/html5/thumbnails/41.jpg)
Hope for the Afflicted:
1024
![Page 42: The Answer to Early Diagnosis & Treatment Monitoring of Alzheimer’s Is in the Eye](https://reader035.vdocument.in/reader035/viewer/2022062515/56649f4d5503460f94c6dde0/html5/thumbnails/42.jpg)
The Answer to Early Diagnosis & TreatmentMonitoring of Alzheimer’s Is in the Eye
“The experimenter who does not know what he is looking for will not understand what he finds.” – Claude Bernard
"Vulnerable plaque formation from obstruction of vasa vasorum by homocysteinylated and oxidized lipoprotein aggregates complexed with microbial remnants and LDL autoantibodies." – McCully, Ravnskov
![Page 43: The Answer to Early Diagnosis & Treatment Monitoring of Alzheimer’s Is in the Eye](https://reader035.vdocument.in/reader035/viewer/2022062515/56649f4d5503460f94c6dde0/html5/thumbnails/43.jpg)
Hope for the Afflicted:
1024
Clinical Approach:
1.Eye Screening2.Immune Health Status3.Tissue Health4.Homeostasis5.Root Causes6.Treatment/Disease Management
![Page 44: The Answer to Early Diagnosis & Treatment Monitoring of Alzheimer’s Is in the Eye](https://reader035.vdocument.in/reader035/viewer/2022062515/56649f4d5503460f94c6dde0/html5/thumbnails/44.jpg)